伴心门边缘到边缘修复通过心房 Septal 关节装置
Felix J Hofmann1, Oliver Dörr1, Bernd Abt2
1Department of Cardiology, University of Giessen, Giessen, Germany.
JACC. Case reports
|August 19, 2024
概括
透导管中枢的修复可以安全地通过现有的心房分流装置进行. 这种方法为患有复杂疾病的患者提供了可行的选择,这些患者需要跨septal访问.
科学领域:
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
- 医疗器械 医疗器械
背景情况:
- 人们越来越多地使用心房分流装置,这引发了对未来的横septal手术的问题.
- 截面接入对于各种心脏干预,包括门修复至关重要.
研究的目的:
- 评估通过现有的心房分流装置进行穿越性通道的可行性和安全性.
- 评估这种方法在患有并发症的患者中对 mitra 门修复的有用性.
主要方法:
- 一个79岁的妇女的病例报告,患有渐进性呼吸障碍和植入的心房分流装置.
- 截面穿孔和两侧门边缘到边缘的修复通过现有的分流装置进行.
主要成果:
- 通过心房短路成功实现了跨septal访问.
- 尽管患者患有并发症,但关节边缘到边缘的修复成功完成.
- 该程序证明了利用现有的分流器进行后续干预的潜力.
结论:
- 截面手术,包括 mitra 门修复,可以通过植入的心房分流装置安全地进行.
- 这种技术可以为复杂解剖或并发症的患者提供有价值的替代方案.
- 需要进一步的研究来探索这种方法的更广泛应用.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


